This study examined the frequency with which subjects with bulimia nervosa (BN) presenting for treatment or follow-up studies had previously received either adequate pharmacologic treatment or cognitive-behavioral therapy (CBT).
Semistructured telephone screening of individuals who called in response to advertisements about research studies was used to establish diagnoses and to clarify prior pharmacologic and psychotherapeutic treatments for BN.
Of 581 women responding, 353 (60.8%) had probable BN.
Overall, 61.4% of these subjects had received psychotherapy (96.7%) but rarely CBT (6.9%). Over one half (63.7%) had received pharmacologic treatment, most commonly with fluoxetine (72.5%). Of those having received any medication treatment, 46.2% were judged to have received at least one adequate trial.
Overall, 35.0% of those previously treated had received at least one prior course of adequate pharmacotherapy or CBT for BN.
Although efficacious treatments for BN have been established, they have not been received by most individuals presenting for further treatment.
Mots-clés Pascal : Boulimie, Antécédent, Traitement, Chimiothérapie, Psychothérapie, Thérapie comportementale, Thérapie cognitive, Epidémiologie, Santé mentale, Etats Unis, Amérique du Nord, Amérique, Homme, Femelle, Trouble comportement alimentaire
Mots-clés Pascal anglais : Bulimia, Antecedent, Treatment, Chemotherapy, Psychotherapy, Behavior therapy, Cognitive therapy, Epidemiology, Mental health, United States, North America, America, Human, Female, Eating disorder
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0100963
Code Inist : 002B18H05B. Création : 16/11/1999.